article
Over the past few years, the landscape of medicines development…
7 May 2014 | By Guido Rasi (Executive Director: European Medicines Agency)
Over the past few years, the landscape of medicines development has shifted. We have seen a decline in the research and development productivity of the pharmaceutical industry. Innovator drug developers have been confronted with the current pressure on healthcare budgets, as well as a wave of patent expiries for blockbuster…